Condition
Renal Cell Cancer Metastatic clinical trials and research
As of November 12, 2026, Find a Trial lists 4 Renal Cell Cancer Metastatic clinical trials that are recruiting, at sites in 4 countries (most in Japan (1), United States (1), Netherlands (1)). By phase: Phase 1 (1), Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 4Countries
Newest Renal Cell Cancer Metastatic clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| High‑dose targeted radiation plus immunotherapy to trigger abscopal responses in metastatic kidney cancer | — | Chūō, Yamanashi | Recruiting | Nov 21, 2025 |
| 177Lu-TLX250 for advanced relapsed or recurrent clear-cell kidney cancer | Phase 3 | Sydney, New South Wales and 4 other locations | Recruiting | Sep 29, 2025 |
| Testing ZM008 alone and with Pembrolizumab in patients with advanced solid tumors | Phase 1 | Boston, Massachusetts and 2 other locations | Recruiting | Jun 11, 2024 |
| Nationwide cohort for renal cell carcinoma data collection | — | Amsterdam, North Holland and 26 other locations | Recruiting | Apr 13, 2022 |
All recruiting trials (4)
-
High‑dose targeted radiation plus immunotherapy to trigger abscopal responses in metastatic kidney cancer
This study will try adding focused, very‑high‑dose radiation to ongoing immunotherapy to see if untreated metastatic kidney tumors shrink in people whose cancer is stable or getting worse on immune therapy.
-
177Lu-TLX250 for advanced relapsed or recurrent clear-cell kidney cancer
This will test whether 177Lu-TLX250, a CAIX-targeting radioligand, helps adults with CAIX-positive advanced or relapsed clear-cell kidney cancer who have had 2–3 prior therapies.
-
Testing ZM008 alone and with Pembrolizumab in patients with advanced solid tumors
This study is testing a new treatment called ZM008, alone and with another drug called Pembrolizumab, to see if it can help patients with advanced solid tumors who have run out of other treatment options.
-
Nationwide cohort for renal cell carcinoma data collection
This study is collecting real-life health information from people with kidney cancer in the Netherlands to help improve treatments and understand their experiences better.
Related topics
Quick answers
How many Renal Cell Cancer Metastatic clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in Japan (1 trial), United States (1 trial), Netherlands (1 trial), Australia (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 1, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.